CLINICAL-LABORATORY, IMMUNOLOGICAL, PATHOGENETIC MANIFESTATIONS OF ANTIPHOSPHOLIPID SYNDROME AND IDENTIFICATION OF EFFECTIVE TREATMENT REGIMENS (REVIEWS)
Main Article Content
Abstract
Antiphospholipid syndrome (APS) is one of the leading causes of thrombosis. According to some estimates, the incidence of APS is about 5 new cases per 100,000 people per year and the prevalence is about 40-50 cases per 100,000 people [1], thus the problem of APS remains one of the most important in medicine.
Article Details
How to Cite
Musakov Mirzokhid Sabitdjanovich, Samatova Lobar Dilmurodovna, Turaxojaeva Sabokhat Sultanshikovna, Salaeva Muborak Saidabdullayevna, & Tursunova Minavvar Ulug’bekovna. (2023). CLINICAL-LABORATORY, IMMUNOLOGICAL, PATHOGENETIC MANIFESTATIONS OF ANTIPHOSPHOLIPID SYNDROME AND IDENTIFICATION OF EFFECTIVE TREATMENT REGIMENS (REVIEWS). Spectrum Journal of Innovation, Reforms and Development, 15, 51–61. Retrieved from https://sjird.journalspark.org/index.php/sjird/article/view/643
Issue
Section
Articles